Baxter (BAX) Tops Q3 EPS by 5c, Beats on Revenues; Boosts FY17 EPS Guidance Above Consensus

Baxter (NYSE: BAX) reported Q3 EPS of $0.64, $0.05 better than the analyst estimate of $0.59. Revenue for the quarter came in at $2.7 billion versus the consensus estimate of $2.66 billion.

• Third-Quarter Revenue of $2.7 Billion Increased 6 Percent on Both a Reported and Operational Basis
• Third-Quarter GAAP Earnings Per Share (EPS) of $0.45; Adjusted EPS of $0.64 Increased 14 Percent
• Expects Full-Year 2017 Sales Growth of 4 Percent on a Reported Basis and 4 to 5 Percent on an Operational Basis
• Expects Full-Year 2017 GAAP EPS of $1.85 to $1.93; Raises Adjusted EPS to $2.40 to $2.43

GUIDANCE:

Baxter sees FY2017 EPS of $2.40-$2.43, versus the consensus of $2.39.

For earnings history and earnings-related data on Baxter (BAX) click here.

You May Also Be Interested In

• Potential Starbucks-Chipotle merger: major opportunity or expensive distraction?
• Daré Bioscience to present sildenafil cream Phase 1 data at SMSNA
• Freedom Broker Upgrades Constellation Brands (STZ) to Buy